Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1)

RAS and PP2A activities converge on epigenetic gene regulation

Julkaisun tekijätAakula Anna, Sharma Mukund, Tabaro Francesco, Nätkin Reetta, Kamila Jesse, Honkanen Henrik, Schapira Matthieu, Arrowsmith Cheryl, Nykter Matti, Westermarck Jukka

KustantajaLife Science Alliance


JournalLife Science Alliance

Tietokannassa oleva lehden nimiLIFE SCIENCE ALLIANCE

Lehden akronyymiLIFE SCI ALLIANCE

Artikkelin numero e202301928



Sivujen määrä17




Rinnakkaistallenteen osoite

RAS-mediated human cell transformation requires inhibition of the tumor suppressor protein phosphatase 2A (PP2A). However, the phosphoprotein targets and cellular processes in which RAS and PP2A activities converge in human cancers have not been systematically analyzed. Here, we discover that phosphosites co -regulated by RAS and PP2A are enriched on proteins involved in epigenetic gene regulation. As examples, RAS and PP2A co -regulate the same phosphorylation sites on HDAC1/2, KDM1A, MTA1/2, RNF168, and TP53BP1. We validate RAS-and PP2A-elicited regulation of HDAC1/2 chromatin recruitment, of RNF168-TP53BP1 interaction, and of gene expression. Consistent with their known synergistic effects in cancer, RAS activation and PP2A inhibition resulted in epigenetic reporter derepression and activation of oncogenic transcription. Transcriptional derepression by PP2A inhibition was associated with an increase in euchromatin and a decrease in global DNA methylation. Collectively, the results indicate that epigenetic protein complexes constitute a signifi-cant point of convergence for RAS hyperactivity and PP2A inhi-bition in cancer. Furthermore, the work provides an important resource for future studies focusing on phosphoregulation of epigenetic gene regulation in cancer and in other RAS/PP2A-regulated cellular processes.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.

Last updated on 2023-30-06 at 13:19